Sector ratings Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.32 EUR | -1.04% |
|
+6.39% | -5.29% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,07900Cr | A | ||||||||
| 64TCr | BBB | ||||||||
| 47TCr | AA | - | |||||||
| 35TCr | AA | ||||||||
| 30TCr | AAA | ||||||||
| 27TCr | A | ||||||||
| 23TCr | A | ||||||||
| 21TCr | A | ||||||||
| 16TCr | AA | ||||||||
| 14TCr | A | ||||||||
| 13TCr | A | ||||||||
| 12TCr | AA | ||||||||
| 11TCr | AA | ||||||||
| 11TCr | AA | ||||||||
| 7.1TCr | AA | ||||||||
| 6.37TCr | - | - | - | - | - | - | - | ||
| 5.7TCr | AA | ||||||||
| 5.33TCr | AA | ||||||||
| 5.25TCr | AA | ||||||||
| Average | 24.3TCr | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
















